Citations (52)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (8)
Srijeyagowri Murugaiyaa Pandiyan, Priyadharshini Shanmugaraj, Jeevitha Priya Manoharan & Subramanian Vidyalakshmi. (2022) A network pharmacological approach to reveal the multidrug resistance reversal and associated mechanisms of acetogenins against colorectal cancer. Journal of Biomolecular Structure and Dynamics 40:24, pages 13527-13546.
Read now
Read now
Mariagrazia Esposito, Ilaria Lagorio, Diego Peroni, Alice Bonuccelli, Alessandro Orsini & Pasquale Striano. (2020) Genomic sequencing in severe epilepsy: a step closer to precision medicine. Expert Review of Precision Medicine and Drug Development 5:2, pages 101-108.
Read now
Read now
Qingling Zhao, Jinlan Wei & Hongying Zhang. (2019) Effects of quercetin on the pharmacokinetics of losartan and its metabolite EXP3174 in rats. Xenobiotica 49:5, pages 563-568.
Read now
Read now
Martyn Howard, Jill Barber, Naved Alizai & Amin Rostami-Hodjegan. (2018) Dose adjustment in orphan disease populations: the quest to fulfill the requirements of physiologically based pharmacokinetics. Expert Opinion on Drug Metabolism & Toxicology 14:12, pages 1315-1330.
Read now
Read now
Fereniki Perperopoulou, Fotini Pouliou & Nikolaos E. Labrou. (2018) Recent advances in protein engineering and biotechnological applications of glutathione transferases. Critical Reviews in Biotechnology 38:4, pages 511-528.
Read now
Read now
Hong Li, Lu Liu, Lei Xie, Dongmei Gan & Xiaoqing Jiang. (2016) Effects of berberine on the pharmacokinetics of losartan and its metabolite EXP3174 in rats and its mechanism. Pharmaceutical Biology 54:12, pages 2886-2894.
Read now
Read now
Xiwei Yu, Guang Yang, Yijie Shi, Chang Su, Ming Liu, Bo Feng & Liang Zhao. (2015) Intracellular targeted co-delivery of shMDR1 and gefitinib with chitosan nanoparticles for overcoming multidrug resistance. International Journal of Nanomedicine 10, pages 7045-7056.
Read now
Read now
Godefridus J Peters & Richard J Honeywell. (2015) Drug transport and metabolism of novel anticancer drugs. Expert Opinion on Drug Metabolism & Toxicology 11:5, pages 661-663.
Read now
Read now
Articles from other publishers (44)
Yizhou Jin & Zhipeng Fan. (2023)
New insights into the interaction between
m6A
modification and
lncRNA
in cancer drug resistance
. Cell Proliferation.
Crossref
Crossref
Seyedehsadaf Asfa, Halil Ibrahim Toy, Reza Arshinchi Bonab, George P. Chrousos, Athanasia Pavlopoulou & Styliani A. Geronikolou. (2023) Soft Tissue Ewing Sarcoma Cell Drug Resistance Revisited: A Systems Biology Approach. International Journal of Environmental Research and Public Health 20:13, pages 6288.
Crossref
Crossref
Bárbara Polónia, Cristina P.R. Xavier, Joanna Kopecka, Chiara Riganti & M. Helena Vasconcelos. (2023) The role of Extracellular Vesicles in glycolytic and lipid metabolic reprogramming of cancer cells: Consequences for drug resistance. Cytokine & Growth Factor Reviews.
Crossref
Crossref
Yang Li, Xiaoyue Zhang, Zhihan Wang, Bowen Li & Huili Zhu. (2023) Modulation of redox homeostasis: A strategy to overcome cancer drug resistance. Frontiers in Pharmacology 14.
Crossref
Crossref
Farbod Bahreini & Nima Rezaei. 2022. Handbook of Cancer and Immunology. Handbook of Cancer and Immunology
1
39
.
Jasmine S. Owen, Aled Clayton & Helen B. Pearson. (2022) Cancer-Associated Fibroblast Heterogeneity, Activation and Function: Implications for Prostate Cancer. Biomolecules 13:1, pages 67.
Crossref
Crossref
Zaoqu Liu, Haijiao Zou, Qin Dang, Hui Xu, Long Liu, Yuyuan Zhang, Jinxiang Lv, Huanyun Li, Zhaokai Zhou & Xinwei Han. (2022) Biological and pharmacological roles of m6A modifications in cancer drug resistance. Molecular Cancer 21:1.
Crossref
Crossref
Hong Lin, Yuxi Wang, Pinghan Wang, Fangyi Long & Ting Wang. (2022) Mutual regulation between N6-methyladenosine (m6A) modification and circular RNAs in cancer: impacts on therapeutic resistance. Molecular Cancer 21:1.
Crossref
Crossref
Song Wang, Long Qian, Tingting Cao, Li Xu, Yan Jin, Hao Hu, Qingsheng Fu, Qian Li, Ye Wang, Jiawei Wang, Yabin Xia & Xiaoxu Huang. (2022) Advances in the Study of CircRNAs in Tumor Drug Resistance. Frontiers in Oncology 12.
Crossref
Crossref
Eda Dogan, Hale Guler Kara, Buket Kosova & Vildan Bozok Cetintas. 2022. Metastasis. Metastasis
163
180
.
Huan Tong, He Wei, Alhaji Osman Smith & Juan Huang. (2022) The Role of m6A Epigenetic Modification in the Treatment of Colorectal Cancer Immune Checkpoint Inhibitors. Frontiers in Immunology 12.
Crossref
Crossref
Mayank Chaudhary. 2022. Plant Secondary Metabolites. Plant Secondary Metabolites
415
435
.
Debasish Basak, Scott Arrighi, Yasenya Darwiche & Subrata Deb. (2021) Comparison of Anticancer Drug Toxicities: Paradigm Shift in Adverse Effect Profile. Life 12:1, pages 48.
Crossref
Crossref
Ana Cristina Gonçalves, Elena Richiardone, Joana Jorge, Bárbara Polónia, Cristina P.R. Xavier, Iris Chiara Salaroglio, Chiara Riganti, M. Helena Vasconcelos, Cyril Corbet & Ana Bela Sarmento-Ribeiro. (2021) Impact of cancer metabolism on therapy resistance – Clinical implications. Drug Resistance Updates 59, pages 100797.
Crossref
Crossref
Xiaobing Han, Liangfeng Chen, Zhongzhou Hu, Liangxin Chen, Peng Sun, Yujun Wang & Yangyang Liu. (2021) Identification of proteins related with pemetrexed resistance by iTRAQ and PRM-based comparative proteomic analysis and exploration of IGF2BP2 and FOLR1 functions in non-small cell lung cancer cells. Journal of Proteomics 237, pages 104122.
Crossref
Crossref
Richard A. Ward, Stephen Fawell, Nicolas Floc’hVikki FlemingtonDarren McKerrecherPaul D. Smith. (2020) Challenges and Opportunities in Cancer Drug Resistance. Chemical Reviews 121:6, pages 3297-3351.
Crossref
Crossref
Yiyan Songyang, Tianbao Song, Zhan Shi, Wen Li, Songyisha Yang & Dejia Li. (2021) Effect of vitamin D on malignant behavior of non-small cell lung cancer cells. Gene 768, pages 145309.
Crossref
Crossref
Batool Fatima, Maryam Jamil, Dilshad Hussain, Adeela Saeed, Fahmida Jabeen, Muhammad Salman Sajid & Muhammad Najam-ul-Haq. 2021. Biochemistry of Drug Resistance. Biochemistry of Drug Resistance
367
386
.
Chaochu Cui, Jianbo Yang, Xiao Li, Dongling Liu, Liwu Fu & Xianwei Wang. (2020) Functions and mechanisms of circular RNAs in cancer radiotherapy and chemotherapy resistance. Molecular Cancer 19:1.
Crossref
Crossref
Bowen Li, Jingwen Jiang, Yehuda G. Assaraf, Hengyi Xiao, Zhe-Sheng Chen & Canhua Huang. (2020) Surmounting cancer drug resistance: New insights from the perspective of N6-methyladenosine RNA modification. Drug Resistance Updates 53, pages 100720.
Crossref
Crossref
Simon Corbett, Shiran Huang, Francesca Zammarchi, Philip W. Howard, Patrick H. van Berkel & John A. Hartley. (2020) The Role of Specific ATP-Binding Cassette Transporters in the Acquired Resistance to Pyrrolobenzodiazepine Dimer–Containing Antibody–Drug Conjugates. Molecular Cancer Therapeutics 19:9, pages 1856-1865.
Crossref
Crossref
Alessandro Dalpiaz, Guglielmo Paganetto, Giada Botti & Barbara Pavan. (2020) Cancer stem cells and nanomedicine: new opportunities to combat multidrug resistance?. Drug Discovery Today 25:9, pages 1651-1667.
Crossref
Crossref
Charles O'Doherty, Joanne Keenan, Michael Henry, Paula Meleady, Indre Sinkunaite, Martin Clynes, Finbarr O'Sullivan, Karina Horgan & Richard Murphy. (2020) Characterisation and proteomic profiling of continuously exposed Cu-resistant variants of the Caco-2 cell line. Toxicology in Vitro 65, pages 104773.
Crossref
Crossref
Maria Condello, Giovanna Mancini & Stefania Meschini. (2020) The Exploitation of Liposomes in the Inhibition of Autophagy to Defeat Drug Resistance. Frontiers in Pharmacology 11.
Crossref
Crossref
Changwen Jing, Ting Wang, Rong Ma, Haixia Cao, Zhuo Wang, Siwen Liu, Dan Chen, Junying Zhang, Yang Wu, Yuan Zhang, Jianzhong Wu & Jifeng Feng. (2020) New genetic variations discovered in KRAS wild‐type cetuximab resistant chinese colorectal cancer patients. Molecular Carcinogenesis 59:5, pages 478-491.
Crossref
Crossref
Xiaofeng Wang, Zhiyuan Xu, Jiancheng Sun, Hang Lv, Yiping Wang, Yixiu Ni, Shangqi Chen, Can Hu, Lijing Wang, Wei Chen & Xiangdong Cheng. (2020) Cisplatin resistance in gastric cancer cells is involved with GPR30‐mediated epithelial‐mesenchymal transition. Journal of Cellular and Molecular Medicine 24:6, pages 3625-3633.
Crossref
Crossref
Guerini, Triggiani, Maddalo, Bonù, Frassine, Baiguini, Alghisi, Tomasini, Borghetti, Pasinetti, Bresciani, Magrini & Buglione. (2019) Mebendazole as a Candidate for Drug Repurposing in Oncology: An Extensive Review of Current Literature. Cancers 11:9, pages 1284.
Crossref
Crossref
Hira Choudhury, Manisha Pandey, Tan Hui Yin, Taasjir Kaur, Gan Wei Jia, S.Q. Lawrence Tan, How Weijie, Eric Koh Sze Yang, Chin Guan Keat, Subrat Kumar Bhattamishra, Prashant Kesharwani, Shadab Md, Nagasekhara Molugulu, Mallikarjuna Rao Pichika & Bapi Gorain. (2019) Rising horizon in circumventing multidrug resistance in chemotherapy with nanotechnology. Materials Science and Engineering: C 101, pages 596-613.
Crossref
Crossref
Qiuhua Luo, Ling Zhang, Cong Luo & Mingyan Jiang. (2019) Emerging strategies in cancer therapy combining chemotherapy with immunotherapy. Cancer Letters 454, pages 191-203.
Crossref
Crossref
Wenxi Yu, Daliu Min, Feng Lin, Shuier Zheng, Lina Tang, Aina He, Haiyan Hu & Zan Shen. (2019)
SKA
1 induces
de novo
MTX
‐resistance in osteosarcoma through inhibiting
FPGS
transcription
. The FEBS Journal 286:12, pages 2399-2414.
Crossref
Crossref
Carlotta Figliola, Estelle Marchal, Brandon R. Groves & Alison Thompson. (2019) A step-wise synthetic approach is necessary to access γ-conjugates of folate: folate-conjugated prodigiosenes. RSC Advances 9:25, pages 14078-14092.
Crossref
Crossref
Tomasz Chmiel, Anna Mieszkowska, Dagmara Kempińska-Kupczyk, Agata Kot-Wasik, Jacek Namieśnik & Zofia Mazerska. (2019) The impact of lipophilicity on environmental processes, drug delivery and bioavailability of food components. Microchemical Journal 146, pages 393-406.
Crossref
Crossref
Zheng Luo, Yang Xu, Enyi Ye, Zibiao Li & Yun-Long Wu. (2019) Recent Progress in Macromolecule-Anchored Hybrid Gold Nanomaterials for Biomedical Applications. Macromolecular Rapid Communications 40:5, pages 1800029.
Crossref
Crossref
Gabriella Spengler, Márió Gajdács, Małgorzata Marć, Enrique Domínguez-Álvarez & Carmen Sanmartín. (2019) Organoselenium Compounds as Novel Adjuvants of Chemotherapy Drugs—A Promising Approach to Fight Cancer Drug Resistance. Molecules 24:2, pages 336.
Crossref
Crossref
Yue Wang, Zehua Wang, Jieni Xu, Jiang Li, Song Li, Min Zhang & Da Yang. (2018) Systematic identification of non-coding pharmacogenomic landscape in cancer. Nature Communications 9:1.
Crossref
Crossref
Danyang Liu, Yang Hu, Ying Guo, Zhu Zhu, Bingzheng Lu, Xuelan Wang & Yijun Huang. (2017) Mycoplasma-associated multidrug resistance of hepatocarcinoma cells requires the interaction of P37 and Annexin A2. PLOS ONE 12:10, pages e0184578.
Crossref
Crossref
Xuchun Liu & Gengyun Sun. (2017) Shikonin enhances Adriamycin antitumor effects by inhibiting efflux pumps in A549 cells. Oncology Letters 14:4, pages 4270-4276.
Crossref
Crossref
Liang Ding, Jing Ren, Dongya Zhang, Yi Li, Xiaofeng Huang, Jianjian Ji, Qingang Hu, Hui Wang, Yanhong Ni & Yayi Hou. (2017) The TLR3 Agonist Inhibit Drug Efflux and Sequentially Consolidates Low-Dose Cisplatin-Based Chemoimmunotherapy while Reducing Side Effects. Molecular Cancer Therapeutics 16:6, pages 1068-1079.
Crossref
Crossref
Emarndeena H Cheteh, Martin Augsten, Helene Rundqvist, Julie Bianchi, Victoria Sarne, Lars Egevad, Vladimir JN Bykov, Arne Östman & Klas G Wiman. (2017) Human cancer-associated fibroblasts enhance glutathione levels and antagonize drug-induced prostate cancer cell death. Cell Death & Disease 8:6, pages e2848-e2848.
Crossref
Crossref
Maryam Majidinia & Bahman Yousefi. (2017) Breast tumor stroma: A driving force in the development of resistance to therapies. Chemical Biology & Drug Design 89:3, pages 309-318.
Crossref
Crossref
Toralf Reimer, Sarah Kempert, Bernd Gerber, Hans-Jürgen Thiesen, Steffi Hartmann & Dirk Koczan. (2016) SLCO1B1*5 polymorphism (rs4149056) is associated with chemotherapy-induced amenorrhea in premenopausal women with breast cancer: a prospective cohort study. BMC Cancer 16:1.
Crossref
Crossref
Sabine Hoja, Markus Schulze, Michael Rehli, Martin Proescholdt, Christel Herold-Mende, Peter Hau & Markus J. Riemenschneider. (2016) Molecular dissection of the valproic acid effects on glioma cells. Oncotarget 7:39, pages 62989-63002.
Crossref
Crossref
Xiaodong Gao, Yongjie Zhang, Yongdong Wang, Yijie Zhang, Yixin Wang, Shuya Liu & Xiaohong Gao. (2016) Influence of verapamil on pharmacokinetics of pristimerin in rats. Biomedical Chromatography 30:6, pages 802-809.
Crossref
Crossref
Zofia Mazerska, Anna Mróz, Monika Pawłowska & Ewa Augustin. (2016) The role of glucuronidation in drug resistance. Pharmacology & Therapeutics 159, pages 35-55.
Crossref
Crossref